Herpes simplex
Herpes simplex is a contagious skin disease caused by infection with the herpes simplex virus (HSV). The clinical features of herpes simplex are clusters of small, unilocular blisters on the skin and mucous membranes, mainly on the face or genitals, and are prone to recurrence; the pathogen is a virus that often occurs on the upper lip or face. The symptoms are local itching first, followed by the appearance of blister-like protrusions containing clear fluid, slight pain, and self-healing after one or two weeks of scab formation. HSV can cause intrauterine infection, and the fetus may be born with various forms of congenital malformations or developmental disorders. It is one of the common causes of the so-called "TORCH" syndrome.
-
Site of disease:
skin -
Infectious :
Contagious -
Frequent population:
All groups -
Related symptoms:
Herpes labialis ulcer slightly itchy lower lip, enlarged and hardened like a cocoon swollen lymph nodes herpes -
Concurrent disease:
Related Drugs
Thymosin for injection
Indication: It is used to treat various primary or secondary T cell deficiency diseases, certain autoimmune diseases, various diseases with low cellular immune function and adjuvant treatment of tumors. Including: 1. Various types of severe hepatitis, chronic active hepatitis, chronic persistent hepatitis and liver cirrhosis; 2. Herpes zoster, genital herpes, condyloma acuminatum, etc.; 3. Prevention of upper respiratory tract infection in bronchitis, bronchial asthma, tuberculosis, etc.; 4. Premature stage of various malignant tumors and chemotherapy, combined with radiotherapy; 5. Lupus erythematosus, rheumatic and rheumatoid diseases, ankylosing spondylitis, Guillain-Barré syndrome, etc.; 6. Aplastic anemia, leukemia, thrombocytopenia, etc.; 7. Viral keratitis, viral conjunctivitis, allergic rhinitis, etc.; 8. Senile premature aging, women's menopausal syndrome, etc.; 9. Multiple furunculosis and facial skin acne, psoriasis, lichen planus, squamous cell carcinoma and epithelial keratosis, etc.; 10. Congenital immunodeficiency in children, etc.
Acyclovir
Indication: 1. Herpes simplex virus infection: Oral use for initial and recurrent cases of genital herpes virus infection; oral use of the product for prevention of recurrent cases. Injection is used for immunocompromised persons. Treatment of initial and recurrent mucocutaneous infections and prevention of recurrent cases; also used for the treatment of herpes simplex encephalitis. 2. Herpes zoster: Oral use for the treatment of herpes in immunocompetents and mild cases in immunocompromised persons. Injection is used for the treatment of severe herpes in immunocompromised persons. 3. Treatment of chickenpox in immunocompromised persons. 4. Topical use for initial and recurrent cases of early genital herpes infection caused by herpes simplex virus and self-limited mucocutaneous herpes simplex in immunocompromised persons. 5. Use its sodium salt to treat acute retinal necrosis. Nucleotide antiviral drugs, used to treat:
Manufacturer:
Zhejiang Charioteer Pharmaceutical Co., Ltd.
Acyclovir
Indication: 1. Herpes simplex virus infection: Oral use for initial and recurrent cases of genital herpes virus infection; oral use of the product for prevention of recurrent cases. Injection is used for immunocompromised persons. Treatment of initial and recurrent mucocutaneous infections and prevention of recurrent cases; also used for the treatment of herpes simplex encephalitis. 2. Herpes zoster: Oral use for the treatment of herpes in immunocompetents and mild cases in immunocompromised persons. Injection is used for the treatment of severe herpes in immunocompromised persons. 3. Treatment of chickenpox in immunocompromised persons. 4. Topical use for initial and recurrent cases of early genital herpes infection caused by herpes simplex virus and self-limited mucocutaneous herpes simplex in immunocompromised persons. 5. Use its sodium salt to treat acute retinal necrosis. Nucleotide antiviral drugs, used to treat:
Manufacturer:
Zhejiang Zhebei Pharmaceutical Co., Ltd.
ACYCLOVIR- acyclovir_tablet
Indication: INDICATIONS & USAGE
Herpes Zoster Infections: Genital Herpes: Chickenpox:
Herpes Simplex
Short-Term Administration: Long-Term Administration:
Chickenpox
The most frequent adverse event reported during 3 clinical trials of treatment of chickenpox with oral acyclovir tablets at doses of 10 to 20 mg/kg 4 times daily for 5 to 7 days or 800 mg 4 times daily for 5 days in 495 patients was diarrhea (3.2%). The 498 patients receiving placebo reported diarrhea (2.2%).
Herpes Zoster Infections: Genital Herpes: Chickenpox:
Herpes Simplex
Short-Term Administration: Long-Term Administration:
Chickenpox
The most frequent adverse event reported during 3 clinical trials of treatment of chickenpox with oral acyclovir tablets at doses of 10 to 20 mg/kg 4 times daily for 5 to 7 days or 800 mg 4 times daily for 5 days in 495 patients was diarrhea (3.2%). The 498 patients receiving placebo reported diarrhea (2.2%).
Manufacturer:
REMEDYREPACK INC.
ACYCLOVIR- acyclovir_tablet
Indication: INDICATIONS & USAGE
Herpes Zoster Infections: Genital Herpes: Chickenpox:
Herpes Simplex
Short-Term Administration: Long-Term Administration:
Chickenpox
The most frequent adverse event reported during 3 clinical trials of treatment of chickenpox with oral acyclovir tablets at doses of 10 to 20 mg/kg 4 times daily for 5 to 7 days or 800 mg 4 times daily for 5 days in 495 patients was diarrhea (3.2%). The 498 patients receiving placebo reported diarrhea (2.2%).
Herpes Zoster Infections: Genital Herpes: Chickenpox:
Herpes Simplex
Short-Term Administration: Long-Term Administration:
Chickenpox
The most frequent adverse event reported during 3 clinical trials of treatment of chickenpox with oral acyclovir tablets at doses of 10 to 20 mg/kg 4 times daily for 5 to 7 days or 800 mg 4 times daily for 5 days in 495 patients was diarrhea (3.2%). The 498 patients receiving placebo reported diarrhea (2.2%).
Manufacturer:
REMEDYREPACK INC.
ACYCLOVIR- acyclovir_tablet
Indication: INDICATIONS & USAGE
Herpes Zoster Infections: Genital Herpes: Chickenpox:
Herpes Simplex
Short-Term Administration: Long-Term Administration:
Chickenpox
The most frequent adverse event reported during 3 clinical trials of treatment of chickenpox with oral acyclovir tablets at doses of 10 to 20 mg/kg 4 times daily for 5 to 7 days or 800 mg 4 times daily for 5 days in 495 patients was diarrhea (3.2%). The 498 patients receiving placebo reported diarrhea (2.2%).
Herpes Zoster Infections: Genital Herpes: Chickenpox:
Herpes Simplex
Short-Term Administration: Long-Term Administration:
Chickenpox
The most frequent adverse event reported during 3 clinical trials of treatment of chickenpox with oral acyclovir tablets at doses of 10 to 20 mg/kg 4 times daily for 5 to 7 days or 800 mg 4 times daily for 5 days in 495 patients was diarrhea (3.2%). The 498 patients receiving placebo reported diarrhea (2.2%).
Manufacturer:
REMEDYREPACK INC.
ACYCLOVIR- acyclovir_tablet
Indication: INDICATIONS & USAGE
Herpes Zoster Infections: Genital Herpes: Chickenpox:
Herpes Simplex
Short-Term Administration: Long-Term Administration:
Chickenpox
The most frequent adverse event reported during 3 clinical trials of treatment of chickenpox with oral acyclovir tablets at doses of 10 to 20 mg/kg 4 times daily for 5 to 7 days or 800 mg 4 times daily for 5 days in 495 patients was diarrhea (3.2%). The 498 patients receiving placebo reported diarrhea (2.2%).
Herpes Zoster Infections: Genital Herpes: Chickenpox:
Herpes Simplex
Short-Term Administration: Long-Term Administration:
Chickenpox
The most frequent adverse event reported during 3 clinical trials of treatment of chickenpox with oral acyclovir tablets at doses of 10 to 20 mg/kg 4 times daily for 5 to 7 days or 800 mg 4 times daily for 5 days in 495 patients was diarrhea (3.2%). The 498 patients receiving placebo reported diarrhea (2.2%).
Manufacturer:
A-S Medication Solutions
ACYCLOVIR- acyclovir_tablet
Indication: INDICATIONS & USAGE
Herpes Zoster Infections: Genital Herpes: Chickenpox:
Herpes Simplex
Short-Term Administration: Long-Term Administration:
Chickenpox
The most frequent adverse event reported during 3 clinical trials of treatment of chickenpox with oral acyclovir tablets at doses of 10 to 20 mg/kg 4 times daily for 5 to 7 days or 800 mg 4 times daily for 5 days in 495 patients was diarrhea (3.2%). The 498 patients receiving placebo reported diarrhea (2.2%).
Herpes Zoster Infections: Genital Herpes: Chickenpox:
Herpes Simplex
Short-Term Administration: Long-Term Administration:
Chickenpox
The most frequent adverse event reported during 3 clinical trials of treatment of chickenpox with oral acyclovir tablets at doses of 10 to 20 mg/kg 4 times daily for 5 to 7 days or 800 mg 4 times daily for 5 days in 495 patients was diarrhea (3.2%). The 498 patients receiving placebo reported diarrhea (2.2%).
Manufacturer:
A-S Medication Solutions
Related Ingredients